cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia (Q24550819)

2

0 references

H Lamouliatte

3

0 references

A de Mascarel

4

0 references

R Samoyeau

5

0 references

R Salamon

6

0 references

F Mégraud

Journal of Clinical Microbiology

7

0 references

language of work or name

English

0 references

publication date

April 2001

0 references

published in

0 references

volume

39

0 references

issue

4

0 references

page(s)

1319-22

0 references

cites work

Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Intrastrain differences in Helicobacter pylori: a key question in mucosal damage?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Serologic detection of infection with cagA+ Helicobacter pylori strains

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Analyses of the cag pathogenicity island of Helicobacter pylori

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=87932

Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

28 November 2018

1 reference

12 December 2020

Absence of Benefit of EradicatingHelicobacter pyloriin Patients with Nonulcer Dyspepsia

1 reference

12 December 2020

1 reference

12 December 2020

Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology

1 reference

12 December 2020

Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment

1 reference

12 December 2020

Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology

1 reference

12 December 2020

CagA and the outcome of Helicobacter pylori infection

1 reference

12 December 2020

The only good Helicobacter pylori is a dead Helicobacter pylori

1 reference

12 December 2020

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

12 December 2020

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

12 December 2020

Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers

1 reference

12 December 2020